Physician profile
Devendra Enjamuri
NPI 1861745135
$6,707.89
in general payments reported to CMS, 2019-2025
13 companies · $1,365 in 2025
The $1,365 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,089 · 2020: $72.77 · 2021: $337 · 2022: $2,445 · 2023: $145 · 2024: $254 · 2025: $1,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911 · Travel and Lodging: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.65 |
| Travel and Lodging | $853.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,635.41 | 2019-2025 | Resolution 360 Ultra Clip, Spyglass, Exalt Model D |
| Olympus Corporation of The Americas | $2,103.80 | 2022 | |
| Abbvie INC. | $200.89 | 2019-2023 | |
| Redhill Biopharma INC. | $144.33 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $143.35 | 2019 | |
| Cook Medical LLC | $124.37 | 2021-2025 | Echotip Insight |
| Merit Medical Systems INC | $110.91 | 2025 | Esophyx |
| Fujifilm Healthcare Americas Corporation | $85.00 | 2024 | |
| Nestle Healthcare Nutrition INC. | $38.37 | 2020-2021 | |
| Olympus America INC. | $36.56 | 2019 | |
| Atricure, INC. | $33.94 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Galvanize Therapeutics, INC | $32.44 | 2025 | Aliya System |
| Medtronic, INC. | $18.52 | 2024 | Nexpowder |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devendra Enjamuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.